Savitz Ryan bought DNTH
March 31, 2026 · Form 4 insider transaction
Savitz Ryan bought 74,367 shares of Dianthus Therapeutics, Inc. at $8.44 per share, a transaction worth $627.7K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
74,367
Price
$8.44
Total value
$627.7K
InsiderSavitz Ryan
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 31, 2026
Filing dateApril 1, 2026
Shares owned after74,367
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2025.